The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $39.13

Today's change-0.21 -0.53%
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $39.13

Today's change-0.21 -0.53%
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down (U.S.)$0.21

GlaxoSmithKline PLC closed lower Wednesday, dropping (U.S.)$0.21 or 0.53% to (U.S.)$39.13. Over the last five days, shares have lost 6.94% and are down 3.02% for the last year to date. This security has underperformed the S&P 500 by 4.92% during the last year.

Key company metrics

  • Open(U.S.) $39.31
  • Previous close(U.S.) $39.34
  • High(U.S.) $39.65
  • Low(U.S.) $39.05
  • Bid / Ask(U.S.) $39.10 / (U.S.) $39.40
  • YTD % change-3.02%
  • Volume5,805,388
  • Average volume (10-day)5,095,246
  • Average volume (1-month)4,178,126
  • Average volume (3-month)3,823,445
  • 52-week range(U.S.) $37.24 to (U.S.) $49.08
  • Beta0.83
  • Trailing P/E7.74×
  • P/E 1 year forward15.38×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.38
  • Dividend yield6.09%
  • Trailing EPS(U.S.) $5.05
Updated February 10 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6,2866,1275,8885,622
Total other revenue--------
Total revenue6,2866,1275,8885,622
Gross profit4,0824,0613,9933,745
Total cost of revenue2,2042,0661,8951,877
Total operating expense6,5395,1045,552-4,437
Selling / general / administrative2,1221,9142,1411,951
Research & development846730731789
Depreciation / amortization109913
Interest expense (income), net operating--------
Unusual expense (income)1,448484838-8,990
Other operating expenses, total-91-99-62-77
Operating income-2531,02333610,059
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4168671529,923
Income after tax-4286471158,038
Income tax, total12220371,885
Net income-3545381498,089
Total adjustments to net income--------
Net income before extra. items-3545381498,089
Minority interest74-1093451
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3545381498,089
Inc. avail. to common incl. extra. items-3545381498,089
Diluted net income-3545381498,089
Dilution adjustment--0----
Diluted weighted average shares4,8384,8774,8744,820
Diluted EPS excluding extraordinary itemsvalue per share-0.070.110.031.68
Dividends per sharevalue per share0.230.190.190.19
Diluted normalized EPSvalue per share0.120.190.160.17